Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA)

CUSIP: 50127T109

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
87,054,674
Total 13F shares
75,320,060
Share change
+185,722
Total reported value
$686,894,075
Put/Call ratio
888%
Price per share
$9.12
Number of holders
131
Value change
-$2,210,555
Number of buys
72
Number of sells
56

Quarterly Holders Quick Answers

What is CUSIP 50127T109?
CUSIP 50127T109 identifies KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q3 2023

As of 30 Sep 2023, Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) was held by 131 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 75,320,060 shares. The largest 10 holders included SUVRETTA CAPITAL MANAGEMENT, LLC, BlackRock Inc., BVF INC/IL, EcoR1 Capital, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), VANGUARD GROUP INC, STATE STREET CORP, Avoro Capital Advisors LLC, Holocene Advisors, LP, and ARMISTICE CAPITAL, LLC. This page lists 131 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.